
Hyperglycemia predicts death in COVID-19 patients
A new study from China found that about half of the patients hospitalized with COVID-19 are hyperglycemic.
A new study from China found that about half of the patients hospitalized with the COVID-19 are hyperglycemic.
These patients had not been diagnosed previously with diabetes. The retrospective study, reported by
The patients (n = 605) had been admitted to 2 hospitals in Wuhan with a fasting blood glucose of 7.0 mmol/L (126 mg/dL) or greater in more than 45% of those without preexisting diabetic conditions.
The study investigators commented, “Glycemic testing and control should be recommended for all COVID-19 patients even if they do not have preexisting diabetes, as most COVID-19 patients are prone to glucose metabolic disorders.”
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.